Standout Papers

A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy 1993 2026 2004 2015 1.6k
  1. A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy (1993)
    F.R. Rosendaal, Suzanne C. Cannegieter et al. Thrombosis and Haemostasis
  2. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study (1993)
    Ted Koster, Jan P. Vandenbroucke et al. The Lancet
  3. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis (1995)
    Ted Koster, Jan P. Vandenbroucke et al. The Lancet
  4. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. (1994)
    Suzanne C. Cannegieter, F.R. Rosendaal et al. Circulation
  5. Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves (1995)
    Suzanne C. Cannegieter, Frits R. Rosendaal et al. New England Journal of Medicine
  6. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis (1992)
    Michael T. Nurmohamed, Harry R. Büller et al. The Lancet

Immediate Impact

2 from Science/Nature 48 standout
Sub-graph 1 of 9

Citing Papers

Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
A Randomized Trial of Genotype-Guided Dosing of Warfarin
2013 Standout

Works of E Briët being referenced

A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
1993 Standout

Author Peers

Author Last Decade Papers Cites
E Briët 5407 765 3591 4297 134 10.2k
Paul A. Kyrle 6131 690 5646 3822 209 11.5k
Michael Makris 6177 746 2151 2126 240 9.5k
Per Morten Sandset 3774 586 4901 3468 312 10.5k
Kenneth A. Bauer 5324 763 7435 6284 200 13.4k
Ian Mackie 4282 555 1747 1774 228 9.4k
Benjamin Brenner 4449 1451 4199 3903 327 11.2k
Sabine Eichinger 4538 457 5607 3563 153 9.2k
Ulrike Nowak‐Göttl 6306 467 3446 1839 228 8.8k
Armando D’Angelo 2937 888 2707 2471 188 9.0k
Ted Koster 6915 297 4153 2126 45 9.0k

All Works

Loading papers...

Rankless by CCL
2026